Wednesday, 15 Aug 2018

You are here

Fractures Augment 10 Year Mortality Risks

This nationwide study of adults (50+ yrs) from Denmark has shown that following a fragility fracture, the 10-years mortality risk was increased, especially in the first year following the fracture. 

A study of over 30,000 women and men followed for at least 10 years after an incident fragility fracture demonstrated excess mortality following all proximal and lower leg fractures. Most occurred in the first year and declined thereafter. (Citation source: bit.ly/2vbjQ1R)

Hip fractures had the highest excess mortality (33% higher in men and 20% higher in women) at one year post-fracture. One-year excess mortality was 20-25% after femur or pelvis, 10% following vertebral, 5-10% following humerus, rib or clavicle, and 3% following lower leg fractures.

These data show that mortality is not just limited to hip fractures. It was previously thought that mortality risk following fracture was primarily related to age, hip fractures or developing immobilization complications (e.g., pneumonia, thromoboses) associated with surgery or hospitalization. 

Thus a wide variety of fragility fractures may contribute to long-term excess mortality.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Persistent Osteoporosis Drug Use Pays Off

Among elderly female Medicare patients, persistent use of osteoporosis medications was associated with reduced risk of fracture and significantly lower total health care costs.

Osteoporosis International reports the results of research examining records of 294,369 women >65 years old, on Medicare and taking osteoporosis medicines for the first time at some point between 2009 and 2011. (Citation Source: bit.ly/2vALm98) 

Early Hip Fracture Surgery Reduces Mortality

CMAJ reports that seniors are more likely to survive a hip fracture if the surgery is done as soon as they’re admitted to the hospital - suggesting hospitals should expedite operating room access for patients whose surgery has already been delayed for nonmedical reasons. (Citation source: bit.ly/2KzdrCt) 

Big Advances for Two Osteoporosis Drugs

New developments with the FDA and new scientific findings are adding momentum to two drugs experts believe are game-changers in osteoporosis treatment.

In May, the FDA approved denosumab (Prolia) for use in patients who have glucocorticoid-induced osteoporosis and are at high risk of fracture. 

Update on Osteoporosis

This session was an update on the management of osteoporosis given by Professor Christian Roux from France.

He emphasised the use of composite risk score like the FRAX. He highlighted that the risk of vertebral fracture is increased by both the recency and severity of previous vertebral fracture. So it is important that those with vertebral fractures are followed up and treated appropriately to prevent subsequent fractures.

Restless Sleep and Inactivity Intertwined in OA

Adults with osteoarthritis (OA) of the knee who frequently experienced restless sleep were less likely to engage in potentially beneficial moderate-to-vigorous physical activity, analysis of data from the Osteoarthritis Initiative found.